RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
Before RDV got approved, the only double-blind placebo-controlled RCTs that had been conducted were NOT Gilead-sponsored. The study showing benefit in patients hsoptialized w severe COVID was sponsored by @NIAIDNews 2/10 https://t.co/82HFFv2hcU
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
@efunkEM PINETREE NEJM study for outpatient and also this more recently
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: ACTT-1 Highly Significant Mortality Reduction in Patients on Supplemental Oxygen: https://t.co/rDofR4mlbP 2/ https://t.c…
RT @nickmmark: Guideline writers about remdesivir https://t.co/j60pyUUHZs
@julie_justo @SIDPharm @accpinfdprn Agree. Also new trial results👇👇 https://t.co/R3z2eW0tBC
@Jim_Ayers @kksheld There are pretty compelling studies that support the treatment. https://t.co/0fqlUSkgsm https://t.co/2O8kJnqVHr https://t.co/O6gT2KJQHO https://t.co/lM78bfqU32
@JamesLynchGTC @Annakhait ...clear that treatment with an antiviral drug alone is not likely to be sufficient for all patients. ===== IOW, Dr. Fauci pushed for an expensive drug that doesn't do much -- same as he did on AIDS. Oh, check out the researchers
1/19 Remdesivir is currently available and still works but not as a prophylaxis CATCO: Max benefits >=55yr on noninvasive O2 https://t.co/YJWTfGUZT9 PINETREE: 3 days cut 87% RR hospitalizations/mortality (molnupiravir 30%) https://t.co/jiskXATiY5 ACT
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
Please read the medical literature on remdesivir. You are so off-target it’s not funny. https://t.co/rpO4GJ07SC https://t.co/zOMyegOLGS
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @nickmmark: Guideline writers about remdesivir https://t.co/j60pyUUHZs
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @nickmmark: Guideline writers about remdesivir https://t.co/j60pyUUHZs
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
Guideline writers about remdesivir https://t.co/j60pyUUHZs
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
@2140btc @vietpham27 @ShadowShook @VPrasadMDMPH Oh, I don’t need to tell you anything. That’s what we have RCT’s for:
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
MedTweetorial: #Tweetorial Author: @DrAndreKalil Type: #Publication Specialty: #InfectiousDisease #ID Topics: #COVID19 #Remdesivir
Remdesivir is still the only FDA approved antiviral for treatment of patients hospitalized with COVID19. 18 months after ACTT1, data continues to confirm the benefits. #URochesterResearch. Thankful to have something in our arsenal.
RT @PaulSaxMD: Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in…
RT @DrAndreKalil: #Remdesivir new trial just published Here are the clinical implications: Canadian trial (CATCO) in hospitalized patients…
Good summary thread of the latest RCT of remdesivir, incorporating data from other studies. Though benefits most evident in those requiring O2, the "wait for worsening" approach in those not on O2 makes little clinical sense--esp with PINETREE data showin